NCT03604133 Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
| NCT ID | NCT03604133 |
| Status | Recruiting |
| Phase | — |
| Sponsor | QuesGen Systems Inc |
| Condition | Arrhythmia |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2017-08-24 |
| Primary Completion | 2023-08-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2017-08-24 with a primary completion date of 2023-08-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.
Eligibility Criteria
Inclusion Criteria: * Physician recommendation to receive the implant in an Ambulatory Surgical Center (ASC) Exclusion Criteria: * N/A
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03604133 clinical trial?
This trial is open to participants of all sexes, studying Arrhythmia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03604133 currently recruiting?
Yes, NCT03604133 is actively recruiting participants. Contact the research team at mike.jarrett@quesgen.com for enrollment information.
Where is the NCT03604133 trial being conducted?
This trial is being conducted at Lehi, United States.
Who is sponsoring the NCT03604133 clinical trial?
NCT03604133 is sponsored by QuesGen Systems Inc. The trial plans to enroll 500 participants.